Novartis | NVS - EPS Earnings Per Share


Novartis reported $1.99 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bausch Health Companies USD 0.78 0.3 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Sanofi EUR 2.17 2.84 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026